menu
    • menu

    Company profile for AcuraStem

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AcuraStem is a California-based biotechnology company employing cutting-edge technology in its efforts to find treatments and cures for neurodegenerative diseases (NDDs). AcuraStem’s team of PhDs, professors, tech entrepreneurs, and successful drug company veterans are employing the latest scientific breakthroughs to address the most challenging, but we believe tractable, health problems of our time, including amyotrophic la...
    AcuraStem is a California-based biotechnology company employing cutting-edge technology in its efforts to find treatments and cures for neurodegenerative diseases (NDDs). AcuraStem’s team of PhDs, professors, tech entrepreneurs, and successful drug company veterans are employing the latest scientific breakthroughs to address the most challenging, but we believe tractable, health problems of our time, including amyotrophic lateral sclerosis (ALS). Our best-in-class technology platform consists of complex cellular models from ALS patient cells and sophisticated assays which permit AcuraStem’s scientists to model patient tissues

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AcuraStemUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    605 E. Huntington Dr., Suite 103 Monrovia, CA 91016-6352
    Telephone
    Telephone
    (213) 290-0635
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://acurastem.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acurastem-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/acurastem

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Acurastem Receives Target ALS Grant For ALS Therapeutics
    Acurastem Receives Target ALS Grant For ALS Therapeutics

    10 Mar 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/acurastem-awarded-target-als-grant-to-advance-therapeutics-targeting-a-core-driver-of-als-302709784.html

    PR NEWSWIRE BIO
    10 Mar 2026
    Share Share
    AcuraStem Welcomes Dr. Marcel van as Chief Scientific Officer
    AcuraStem Welcomes Dr. Marcel van as Chief Scientific Officer

    05 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurastem-welcomes-dr-marcel-van-der-brug-as-chief-scientific-officer-302323134.html

    PR NEWSWIRE
    05 Dec 2024
    Share Share
    AcuraStem Enters into Agreement with Takeda to Advance PIKFYVE Therapeutics
    AcuraStem Enters into Agreement with Takeda to Advance PIKFYVE Therapeutics

    26 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acurastem-enters-into-a-license-agreement-with-takeda-to-advance-pikfyve-therapeutics-301937595.html

    PR NEWSWIRE
    26 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search